Literature DB >> 28293759

Serious fungal diseases in the Republic of Uzbekistan.

S A Tilavberdiev1, D W Denning2, N N Klimko3.   

Abstract

We have undertaken the first and preliminary estimation of severe and chronic mycotic diseases in the Republic of Uzbekistan, using a model proposed by LIFE (Leading International Fungal Education). Calculation was carried out based on data from 2014. Published results describing mycoses in Uzbekistan were identified. In the absence of published or official data, information about the frequency of mycoses from scientific literature elsewhere in groups at risk of development of fungal infections were taken into account. We also utilized methodology used in analogous estimations of mycoses in the Russian Federation. We estimate that of the 30.8 million population, 536,978 people (1.8% of the population) were affected by severe and chronic mycotic diseases. In 2014, there were 12,351 cases of acute invasive fungal diseases and 524,627 cases of chronic fungal diseases, including 1,941 cases of chronic pulmonary aspergillosis. The most frequent problems were recurrent vulvovaginal candidiasis (513,600 cases), trichophytosis of the scalp (6,414), and relapsed oral candidiasis (4,950). Results of the investigation indicate a significant prevalence of mycoses in the Republic of Uzbekistan.

Entities:  

Mesh:

Year:  2017        PMID: 28293759     DOI: 10.1007/s10096-017-2926-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  18 in total

Review 1.  Projecting the medical costs of AIDS and ARC in the United States.

Authors:  J W Hay; D H Osmond; M A Jacobson
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1988

2.  Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007).

Authors:  O Lortholary; J-P Gangneux; K Sitbon; B Lebeau; F de Monbrison; Y Le Strat; B Coignard; F Dromer; S Bretagne
Journal:  Clin Microbiol Infect       Date:  2011-06-10       Impact factor: 8.067

Review 3.  The link between fungi and severe asthma: a summary of the evidence.

Authors:  D W Denning; B R O'Driscoll; C M Hogaboam; P Bowyer; R M Niven
Journal:  Eur Respir J       Date:  2006-03       Impact factor: 16.671

4.  Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China.

Authors:  H Xu; L Li; W-J Huang; L-X Wang; W-F Li; W-F Yuan
Journal:  Clin Microbiol Infect       Date:  2011-10-25       Impact factor: 8.067

5.  The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients.

Authors:  S Perkhofer; C Lass-Flörl; M Hell; G Russ; R Krause; M Hönigl; C Geltner; J Auberger; G Gastl; M Mitterbauer; B Willinger; P Knöbl; G Resch; R Waldner; A Makrai; G Hartmann; M Girschikofsky; R Greil
Journal:  Int J Antimicrob Agents       Date:  2010-10-13       Impact factor: 5.283

6.  Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey.

Authors:  Betsy Foxman; Ryan Muraglia; Jean-Paul Dietz; Jack D Sobel; Julian Wagner
Journal:  J Low Genit Tract Dis       Date:  2013-07       Impact factor: 1.925

7.  Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults.

Authors:  David W Denning; Alex Pleuvry; Donald C Cole
Journal:  Med Mycol       Date:  2012-12-04       Impact factor: 4.076

8.  The burden of serious fungal diseases in Russia.

Authors:  N Klimko; Y Kozlova; S Khostelidi; O Shadrivova; Y Borzova; E Burygina; N Vasilieva; D W Denning
Journal:  Mycoses       Date:  2015-10       Impact factor: 4.377

9.  Global access to antifungal therapy and its variable cost.

Authors:  Matthew Kneale; Jennifer S Bartholomew; Emma Davies; David W Denning
Journal:  J Antimicrob Chemother       Date:  2016-08-10       Impact factor: 5.790

10.  Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis.

Authors:  Joanne Armstead; Julie Morris; David W Denning
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

View more
  4 in total

1.  An Estimate of Severe and Chronic Fungal Diseases in the Republic of Kazakhstan.

Authors:  Vadim M Kemaykin; Nariman B Tabinbaev; Mahira S Khudaibergenova; Anastasia A Olifirovich; Layzzat M Abdrakhmanova; David W Denning; Nikolai Klimko
Journal:  J Fungi (Basel)       Date:  2018-03-08

2.  The Burden of Serious Fungal Infections in Tajikistan.

Authors:  Oktam I Bobokhojaev; Ali Osmanov; Samariddin P Aliev; Asliddin S Radjabzoda; Ziyovuddin T Avgonov; Safarbek T Manonov; David W Denning
Journal:  J Fungi (Basel)       Date:  2019-07-21

Review 3.  The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance.

Authors:  Md Rezaul Islam; Md Mominur Rahman; Md Tanjimul Ahasan; Nadia Sarkar; Shopnil Akash; Mahfuzul Islam; Fahadul Islam; Most Nazmin Aktar; Mohd Saeed; Md Harun-Or-Rashid; Md Kawsar Hosain; Md Saidur Rahaman; Sadia Afroz; Shabana Bibi; Md Habibur Rahman; Sherouk Hussein Sweilam
Journal:  Environ Sci Pollut Res Int       Date:  2022-08-19       Impact factor: 5.190

Review 4.  Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision.

Authors:  Felix Bongomin; Sara Gago; Rita O Oladele; David W Denning
Journal:  J Fungi (Basel)       Date:  2017-10-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.